|
Akums Drugs & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
7467.56 Cr.
|
P/BV
|
2.32
|
Book Value (Rs.)
|
204.41
|
|
52 Week High/Low (Rs.)
|
623/405
|
FV/ML
|
2/1
|
P/E(X)
|
22.08
|
|
Bookclosure
|
|
EPS (Rs.)
|
21.49
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| PER SHARE RATIOS | | | | |
| | | | | |
| Basic EPS (Rs.) | 22.60 | -0.28 | 6.63 | -17.65 |
| Diluted EPS (Rs.) | 22.60 | -0.28 | 6.63 | -17.65 |
| Cash EPS (Rs.) | 32.48 | 8.84 | 14.74 | -21.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 199.01 | 50.36 | 50.56 | 87.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 199.01 | 50.36 | 50.56 | 87.39 |
| Revenue From Operations / Share (Rs.) | 268.98 | 292.05 | 255.47 | 513.30 |
| PBDIT / Share (Rs.) | 33.74 | 10.97 | 26.84 | -9.66 |
| PBIT / Share (Rs.) | 23.72 | 2.19 | 18.96 | -22.89 |
| PBT / Share (Rs.) | 22.55 | -3.16 | 10.52 | -27.04 |
| Net Profit / Share (Rs.) | 22.45 | 0.05 | 6.85 | -35.10 |
| NP After MI And SOA / Share (Rs.) | 22.09 | -0.28 | 6.63 | -35.30 |
| | | | | |
| PROFITABILITY RATIOS | | | | |
| | | | | |
| PBDIT Margin (%) | 12.54 | 3.75 | 10.50 | -1.88 |
| PBIT Margin (%) | 8.81 | 0.75 | 7.42 | -4.46 |
| PBT Margin (%) | 8.38 | -1.08 | 4.11 | -5.26 |
| Net Profit Margin (%) | 8.34 | 0.01 | 2.68 | -6.83 |
| NP After MI And SOA Margin (%) | 8.21 | -0.09 | 2.59 | -6.87 |
| Return on Networth / Equity (%) | 11.09 | -0.56 | 13.22 | -40.60 |
| Return on Capital Employeed (%) | 11.27 | 1.36 | 13.55 | -9.11 |
| Return On Assets (%) | 8.22 | -0.11 | 2.90 | -8.22 |
| Long Term Debt / Equity (X) | 0.00 | 0.11 | 0.16 | 0.02 |
| Total Debt / Equity (X) | 0.00 | 0.69 | 0.74 | 0.57 |
| Asset Turnover Ratio (%) | 1.08 | 1.23 | 1.15 | 0.00 |
| | | | | |
| LIQUIDITY RATIOS | | | | |
| | | | | |
| Current Ratio (X) | 2.54 | 1.60 | 1.52 | 1.49 |
| Quick Ratio (X) | 1.78 | 1.08 | 0.94 | 0.91 |
| Inventory Turnover Ratio (X) | 6.28 | 3.35 | 2.79 | 0.00 |
| | | | | |
| COVERAGE RATIOS | | | | |
| | | | | |
| Interest Coverage Ratio (%) | 14.93 | 3.10 | 8.30 | -4.15 |
| Interest Coverage Ratio (Post Tax) (%) | 10.45 | 1.53 | 4.73 | -13.30 |
| | | | | |
| VALUATION RATIOS | | | | |
| | | | | |
| Enterprise Value (Cr.) | 6720.16 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 1.63 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 13.01 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.76 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 2.38 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 1.76 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.04 | 0.00 | 0.00 | 0.00 |
